317 related articles for article (PubMed ID: 19044179)
1. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a review. III. Angiotensin-converting enzyme inhibitors.
Ascenção R; Fortuna P; Reis I; Carneiro AV
Rev Port Cardiol; 2008 Sep; 27(9):1169-87. PubMed ID: 19044179
[TBL] [Abstract][Full Text] [Related]
2. [Recent advances and limitations of medical treatment on heart failure].
Momomura S
Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
[TBL] [Abstract][Full Text] [Related]
3. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
Weir R; McMurray JJ
Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
[TBL] [Abstract][Full Text] [Related]
4. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
5. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
Saha SA; Molnar J; Arora RR
Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
Thanikachalam S; Manchanda SC
Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
[TBL] [Abstract][Full Text] [Related]
7. Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction.
Gradman AH; Papademetriou V
Am Heart J; 2009 Jun; 157(6 Suppl):S17-23. PubMed ID: 19450720
[TBL] [Abstract][Full Text] [Related]
8. Effect of angiotensin-converting enzyme inhibitors in left ventricular dysfunction: results of the studies of left ventricular dysfunction in the context of other similar trials.
Yusuf S; Garg R; McConachie D
J Cardiovasc Pharmacol; 1993; 22 Suppl 9():S28-35. PubMed ID: 7514238
[TBL] [Abstract][Full Text] [Related]
9. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
10. Cross-sectional study of heart failure therapy with angiotensin converting enzyme inhibitors and digoxin.
Mahmood SA; Hussein GM; Hamza EA
Saudi Med J; 2004 Aug; 25(8):1060-5. PubMed ID: 15322598
[TBL] [Abstract][Full Text] [Related]
11. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of heart failure with ACE inhibitors--"evidence-based medicine" and clinical reality].
Auer J; Berent R; Kirchgatterer A; Weber T; Mayr H; Maurer E; Eber B
Wien Med Wochenschr; 1999; 149(21-22):587-92. PubMed ID: 10666823
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
Vijan SG
J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
[TBL] [Abstract][Full Text] [Related]
15. Heart failure due to left ventricular systolic dysfunction: treatment at discharge from hospital and at one year.
Houpe D; Peltier M; Cohen-Solal A; Béguin M; Lévy F; Slama M; Chapelain K; Tribouilloy C
Int J Cardiol; 2005 Sep; 103(3):286-92. PubMed ID: 16098391
[TBL] [Abstract][Full Text] [Related]
16. Management of hypertension in chronic heart failure.
Manickavasagam S; Merla R; Koerner MM; Fujise K; Kunapuli S; Rosanio S; Barbagelata A
Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):423-33. PubMed ID: 19379066
[TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction--a meta-analysis.
Abdulla J; Pogue J; Abildstrøm SZ; Køber L; Christensen E; Pfeffer MA; Yusuf S; Torp-Pedersen C
Eur J Heart Fail; 2006 Jan; 8(1):90-6. PubMed ID: 16054435
[TBL] [Abstract][Full Text] [Related]
18. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
19. Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease.
Vonder Muhll I; Liu P; Webb G
Int J Cardiol; 2004 Dec; 97 Suppl 1():25-33. PubMed ID: 15590076
[TBL] [Abstract][Full Text] [Related]
20. [Revised insights and therapeutic goals in the treatment of chronic heart failure].
van Veldhuisen DJ
Ned Tijdschr Geneeskd; 1999 Jul; 143(29):1507-11. PubMed ID: 10443272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
